Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients.

Podcast: Play in new window | Download

Subscribe: Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

• Diffuse large B-cell lymphoma
• CAR T-cell Therapy
• Bispecific Antibodies
• Diffuse Large B-Cell Lymphoma: Effective Practices for Meaningful Care Conversations in a Changing Landscape
• You and Your Doctor: Actively Participating in Your Care: A Toolkit For Those Living With Or Caring For Someone With Diffuse Large B-Cell Lymphoma (DLBCL)

Additional LLS Support Resources: 

• Information Specialists 
• Free Nutrition Consultations
• Financial support
• Free telephone/web patient programs 
• Free booklets 
• Clinical Trial Support Center
• Young Adult Resources
• Online chats 
• Support groups 
• Caregiver support 
• Caregiver Workbook
• Advocacy and Public Policy
• Survivorship Workbook
• LLS Community
• Mental Health Resources

Support for this episode provided by Genmab US, Inc.